Anthelmintic Activity of Punicalagin from nogeissus Leiocarpus [PDF]
Leaves of Anogeissus leiocarpus Guill. & Perr. have been traditionally used as an African botanical treatment for parasitic worm infections in both humans and livestock. This current study documents the presence of punicalagin isomers (α & β) and its galloyl ester, 1-O-galloyl-punicalagin as major components in the leaf extract of A.
Carrie Waterman +6 more
openaire +1 more source
Pomegranate ellagitannins inhibit α-glucosidase activity in vitro and reduce starch digestibility under simulated gastro-intestinal conditions [PDF]
Pomegranate extract was tested for its ability to inhibit α-amylase and α-glucosidase activity. Pomegranate extract strongly inhibited rat intestinal α-glucosidase in vitro whereas it was a weak inhibitor of porcine α-amylase. The inhibitory activity was
BELLESIA, ANDREA +2 more
core +1 more source
Punicalagin Induces Serum Low‐Density Lipoprotein Influx to Macrophages [PDF]
High levels of circulating low‐density lipoprotein (LDL) are a primary initiating event in the development of atherosclerosis. Recently, the antiatherogenic effect of polyphenols has been shown to be exerted via a mechanism unrelated to their antioxidant capacity and to stem from their interaction with specific intracellular or plasma proteins. In this
Dana Atrahimovich +4 more
openaire +2 more sources
Potentiated virucidal activity of pomegranate rind extract (PRE) and punicalagin against Herpes simplex virus (HSV) when co-administered with zinc (II) ions, and antiviral activity of PRE against HSV and aciclovir-resistant HSV [PDF]
Background There is a clinical need for new therapeutic products against Herpes simplex virus (HSV). The pomegranate, fruit of the tree Punica granatum L, has since ancient times been linked to activity against infection. This work probed the activity of
Bugert, Joachim J. +3 more
core +3 more sources
Punicalagin Regulates Key Processes Associated with Atherosclerosis in THP-1 Cellular Model
Atherosclerosis may lead to cardiovascular diseases (CVD), which are the primary cause of death globally. In addition to conventional therapeutics for CVD, use of nutraceuticals that prevents cholesterol deposition, reduce existing plaques and hence anti-
Sanaa Almowallad +5 more
doaj +1 more source
Ellagitannin-rich bioactive extracts of Tuberaria lignosa: insights into the radiation-induced effects in the recovery of high added-value compounds [PDF]
Ellagitannins are polyphenols responsible for a number of bioactivities and health-promoting effects. These industrially important molecules can be affected by post-harvest treatments and recovery processes, but little is known about the irradiation ...
Antonio, Amilcar L. +6 more
core +1 more source
This investigation focused on the qualitative and quantitative composition of polyphenolic compounds of Mediterranean northern shore Cistus creticus and six further, partly sympatric Cistus species (C. albidus, C. crispus, C. ladanifer, C. monspeliensis,
Brigitte Lukas +5 more
doaj +1 more source
Foliar Application of a Biostimulant Based on Fermented Pomegranate Waste Increases Tomato Yield in Greenhouse. [PDF]
The use of biostimulants can help to mitigate the conditions of biotic and abiotic stresses in crops by enhancing the crop yield and product nutrients. The novelty of this research was to produce a biostimulant for the tomato cultivation through fermentation of pomegranate waste, evaluating in the crop the effect on the growth, development, and quality
Abdón-Aguilar G +7 more
europepmc +2 more sources
In silico prediction of inhibitory potential of a punicalagin β-anomer against SARS-COV-2 main protease (MPRO) [PDF]
The pandemic caused by the new coronavirus has resulted in a global health emergency and has prompted an urgent need for new treatment strategies. No target-specific drugs are currently available for SARS-CoV-2, but new drug candidates targeting the ...
Norberto Monteiro +4 more
doaj +1 more source
Identification of Hydrolyzable Tannins (Punicalagin, Punicalin and Geraniin) as Novel inhibitors of Hepatitis B Virus Covalently Closed Circular DNA [PDF]
The development of new agents to target HBV cccDNA is urgently needed because of the limitations of current available drugs for treatment of hepatitis B.
Cai, Dawei +6 more
core +1 more source

